The Advanced Medical Technology Association (AdvaMed) has expressed support for the Trump administration’s artificial intelligence (AI) action plan.

Brain implant company Neuralink aims to generate $1bn by 2031 following the implantation of its brain-computer interface (BCI) chips in 20,000 people.

Becton, Dickinson and Company (BD) has announced a trial utilising the BD Libertas Wearable Injector for subcutaneous delivery of biologics.

The FDA has granted 510(k) clearance for Philips’ latest UroNav version, an advancement in image-guided navigation for prostate cancer care.

On 20 January 2025, the Trump administration called for a suspension of foreign aid, including global health initiatives such as the US President's Emergency Plan for AIDS Relief (PEPFAR).

Boston Scientific has raised its 2025 profit outlook to between $2.95 and $2.99 per share amid strong Q2 performance in its cardiovascular unit, driven in large part by the uptake of its Farapulse ...

Following a period of relative dormancy, research and development in the Alzheimer’s disease space is booming. And mounting attention, both in the development of disease modifying therapies (DMTs) and ...

Roche’s Elecsys pTau181 test has secured CE Mark approval, marking a development in ruling out Alzheimer's disease.

The European Commission (EC) has approved a €403m ($473.3m) public funding package to support medical device innovation in the bloc.

Nestmedic has chosen Curavit Clinical Research to spearhead the US clinical study of the remote prenatal monitoring solution, PregnaOne.

Despite its clinical importance, the global ICP monitoring market remains small, slow-growing, and resistant to disruption.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has shared new proposals intended to improve access to the latest medical device technologies for UK patients.